What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 00014/0520.


Boots Dual Action Athlete's Foot Spray

PATIENT INFORMATION LEAFLET

Boots Dual Action Athlete’s Foot Spray

Tolnaftate

Effectively treats and prevents athlete’s foot

Relieves skin irritation

Fast drying

Read all of this label for full instructions.

What this medicine is for

An anti-fungal spray for the treatment and prevention of athlete’s foot. Also effective for other skin conditions where tenderness and sweating cause skin irritation, such as dhobie itch (groin ringworm), prickly heat.

Before you use this medicine

Do not use:

If you are allergic to any of the ingredients

You can use this medicine if you are pregnant or breastfeeding.

How to use this medicine

Shake well before use. Hold the can 15 cm (6 inches) from the skin before spraying.

Wash and thoroughly dry the affected area

Spray the affected area liberally

If you have athlete’s foot, spray the socks and inside of shoes with powder as well

Adults and children of 2 years and over:

Apply morning and night.

Continue treatment for at least one week after the condition has cleared up, to stop it coming back.

For use on the skin only.

Avoid contact with eyes.

Do not use on children under 2 years, unless your doctor tells you to.

If symptoms worsen talk to your doctor.

If symptoms do not go away within 10 days, talk to your doctor.

Possible side effects

Most people will not have problems, but some may get some.

If you get any of these stop using the spray and see a doctor:

Skin irritation

Contact dermatitis (redness and swelling of the skin)

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

Do not store above 25°C.

Keep all medicines out of the sight and reach of children.

Use by the date on the base of can.

Active ingredient

This spray powder contains Tolnaftate 0.12% w/w delivering a topical application of Tolnaftate 1% w/w.

Also contains: dimethyl ether, denatured alcohol, talc, disteardimonium hectorite.

PL 00014/0520

Text prepared 3/15

Manufactured for the Marketing Authorisation holder

The Boots Company PLC
Nottingham
NG2 3AA

by

Colep Laupheim GmbH & Co.
KG Fockestr
12 88471 Laupheim
Germany

Danger: Extremely flammable aerosol. Pressurised container. May burst if heated. Keep away from heat, hot surfaces, sparks, open flames or any incandescent material and other ignition sources. No smoking. Do not pierce or burn, even after use. Do not use in confined areas. Do not use near or place on painted or polished surfaces. Avoid inhalation. Protect from sunlight. Do not expose to temperatures exceeding 50 °C/122 °F. If you need more advice ask your pharmacist..

Extremely Flammable

Solvent abuse can kill instantly